R&D News | pharmaphorum

News

Beautiful woman using tissue while sneezing in park

Allergy Therapeutics suffers phase 3 birch allergy jab trial...

UK-based Allergy Therapeutics has suffered a setback after phase 3 results from the B301 trial of its latest birch allergy product failed to reduce symptoms.

News

Imara raises $63m for sickle cell drug trials

US biotech Imara has raised $63 million for clinical development of its sickle cell disease drug, which is in mid-stage development.

News

Human Internal Organic - Human Heart, medical concept.

Esperion's cholesterol-lowering pill works when statins fail

A cholesterol lowering daily pill from US pharma Esperion, which can be used when statins are not working in high-risk patients, is edging closer to the market after a phase 3 trial success

News

Servier and Oncodesign announce Parkinson's R&D tie-up

Servier and Oncodesign have announced a strategic partnership for R&D into potential drug candidates for Parkinson’s disease.

News

NICE backs interim funding for J&J/Takeda myeloma regimen

A three-drug regimen for multiple myeloma based on Johnson & Johnson’s Darzalex, Takeda’s Velcade and dexamethasone will be made available to patients in England, but only via the Cance

News